MAC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
MAC is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock shows a short-term bullish technical setup and supportive options sentiment, but there is no recent news catalyst, no strong proprietary buy signal, and analyst views are mixed. For an impatient investor, the current pre-market price near resistance makes the entry less attractive today than waiting for a better setup.
MAC is in a short-term uptrend: MACD histogram is positive and expanding, and moving averages are bullish with SMA_5 > SMA_20 > SMA_200. RSI_6 at 69.6 is near overbought territory but not extreme. Price at 22.83 is close to first resistance (R1 22.777) and below R2 23.113, while pivot is 22.232 and support sits at 21.688. Overall, the trend is constructive, but the stock is already pressing resistance in pre-market rather than offering an obvious low-risk entry.
Analyst sentiment has improved recently, with multiple target increases. Scotiabank upgraded to Outperform and raised its target to $24, Mizuho kept Outperform with a $24 target, Citi raised its target to $24, and Ladenburg remains positive with a $27 target. Technical momentum is also supportive, and the options flow is leaning bullish. Hedge funds and insiders are neutral, so there is no selling pressure from those groups.
There is no news in the recent week, so there is no fresh event-driven catalyst. Goldman Sachs still has a Sell rating, JPMorgan has an Underweight rating, and the consensus remains mixed rather than strongly bullish. The stock is near resistance after a pre-market move, and the similar-pattern trend data implies downside risk over the next week and month. No recent congress trading data and no notable politician/influencer activity were reported.
No usable latest-quarter financial snapshot was provided, so there is no confirmed quarter-by-quarter revenue, FFO, or earnings detail to assess. The only financial read-through in the analyst notes is that Q1 earnings led to modest FY guidance raises for much of the retail REIT group and same-store NOI growth trended ahead of guidance, which is a favorable sector-level signal. However, company-specific latest quarter financials were not available in the dataset.
Analyst sentiment is mixed but improving. Recent price target changes were mostly upward: Scotiabank to $24 with Outperform, Mizuho to $24 with Outperform, Citi to $24 with Neutral, Evercore to $22 with In Line, and Ladenburg to $27 with Buy, while Goldman remained Sell at $19 and JPMorgan remained Underweight at $19. The pros view is that MAC has catalysts from its Path Forward plan and potential NOI growth improvement; the cons view is that some firms still see limited upside or downside risk, so Wall Street is not uniformly bullish.
